Abstract:Photodynamic therapy (PDT) is a minimally invasive treatment for several diseases. It combines light energy with a photosensitizer (PS) to destroy the targeted cells or tissues. A PS itself is a non-toxic substance, but it becomes toxic to the target cells through the activation of light at a specific wavelength. There are some limitations of PDT, although it has been used in clinical studies for a long time. Two-photon excitation (TPE) and upconversion (UC) for PDT have been recently developed. A TPE nanoparticle-based PS combines the advantages of TPE and nanotechnology that has emerged as an attractive therapeutic agent for near-infrared red (NIR) light-excited PDT, whilst UC is also used for the NIR light-triggered drug release, activation of 'caged' imaging, or therapeutic molecules during PDT process for the diagnosis, imaging, and treatment of cancers. Methods: Nine electronic databases were searched, including WanFang Data, PubMed, Science Direct, Scopus, Web of Science, Springer Link, SciFinder, and China National Knowledge Infrastructure (CNKI), without any language constraints. TPE and UCNP were evaluated to determine if they had different effects from PDT on cancers. All eligible studies were analyzed and summarized in this review. Results: TPE-PDT and UCNP-PDT have a high cell or tissue penetration ability through the excitation of NIR light to activate PS molecules. This is much better than the conventional PDT induced by visible or ultraviolet (UV) light. These studies showed a greater PDT efficacy, which was determined by enhanced generation of reactive oxygen species (ROS) and reduced cell viability, as well as inhibited abnormal cell growth for the treatment of cancers. Conclusions: Conventional PDT involves Type I and Type II reactions for the generation of ROS in the treatment of cancer cells, but there are some limitations. Recently, TPE-PDT and UCNP-PDT have been developed to overcome these problems with the help of nanotechnology in in vitro and in vivo studies.

Photodynamic Therapy of Cancers With Internal Light Sources: Chemiluminescence, Bioluminescence, and Cerenkov Radiation

Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors

X-ray excited luminescent nanoparticles for deep photodynamic therapy

Internal Light Sources‐Mediated PDT Nanoplatforms: Hope for the Resolution of Traditional Penetration Problem

The Current Status of Photodynamic Therapy in Cancer Treatment

A Review of Light Sources and Enhanced Targeting for Photodynamic Therapy

Photodynamic Therapy for Cancer: Mechanisms, Photosensitizers, Nanocarriers, and Clinical Studies.

Beyond External Light: On-Spot Light Generation or Light Delivery for Highly Penetrated Photodynamic Therapy

Comparison of the Differences between Two-Photon Excitation, Upconversion, and Conventional Photodynamic Therapy on Cancers in In Vitro and In Vivo Studies

Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions

Photodynamic Therapy: Current Status and Future Directions

Recent advances in photosensitizer materials for light‐mediated tumor therapy

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges

Upconversion-based Photodynamic Cancer Therapy

Recent Progress in Upconversion Photodynamic Therapy

Hybrid Nanoparticle Composites Applied to Photodynamic Therapy: Strategies and Applications

Scintillating Nanoparticles As Energy Mediators for Enhanced Photodynamic Therapy

Photodynamic Therapy Based on Organic Small Molecular Fluorescent Dyes

Nanoparticles in photodynamic therapy: An emerging paradigm

A new era of cancer phototherapy: mechanisms and applications

Recent Advances of Photoactive Near-Infrared Carbon Dots in Cancer Photodynamic Therapy